Brind.

Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.

2 reports, 0 independent Updated Jul 3

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.

Who's involved

What this event is mainly about

Inovio Pharmaceuticals Piper Sandler Companies Securities and Exchange Commission

Keep exploring

The entities involved

Inovio Pharmaceuticals
American biotechnology company
- Inovio Pharmaceuticals and Synlogic, Inc. are identified as competing small-cap healthcare companies.Sat 10:40
Piper Sandler Companies
American financial services company
- Investors are comparing the financial profiles of Nasdaq, Inc. and Piper Sandler Companies.Sat 10:24
Securities and Exchange Commission
government agency of the Philippines
- BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
- Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

Piper Sandler Companies and Comfort Systems USA demonstrated strong execution in their respective markets on August 25, 2026.Aug 27

Coverage

Newest first; wire copies grouped

Jul 3Unknown outlet
Jul 3Unknown outlet